Gelonghui August 21st | Chalkis Health Industry (000972.SZ) announced that the purpose of launching the 2023 Restricted Stocks Incentive Plan is to further establish and improve the company's long-term incentive mechanism, attract and retain outstanding talents, effectively combine the interests of shareholders, company, and core team individuals, collectively focus on the company's long-term development, bring sustainable returns to shareholders; advocate the concept of mutual continuous development between the company and individuals, build a community of shared interests among shareholders, company, and employees, motivate the enthusiasm of core talents, promote the company's long-term stable development; establish a combination of long-term and short-term compensation incentive system through various means such as salary and equity, focusing on win-win situations for company's long-term value, shareholder value, and talent value. Considering the current market environment, the company's operation situation, and factors such as fluctuations in the company's stock price, with the company's long-term development and employees' interests in mind, the company has decided to terminate the implementation of the 2023 Restricted Stocks Incentive Plan, along with cancelling all related documents associated with it.